|
TMX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.132030E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.759700E-02 |
| Normal-vs-Stage2 |
6.628800E-01 |
| Normal-vs-Stage3 |
5.646600E-01 |
| Normal-vs-Stage4 |
7.432800E-01 |
| Stage1-vs-Stage2 |
3.947400E-01 |
| Stage1-vs-Stage3 |
3.807600E-02 |
| Stage1-vs-Stage4 |
4.696800E-01 |
| Stage2-vs-Stage3 |
4.361400E-01 |
| Stage2-vs-Stage4 |
9.390200E-01 |
| Stage3-vs-Stage4 |
5.763600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.519800E-02 |
| Normal-vs-AfricanAmerican |
3.616400E-01 |
| Normal-vs-Asian |
7.163000E-01 |
| Caucasian-vs-AfricanAmerican |
4.995200E-01 |
| Caucasian-vs-Asian |
2.419600E-01 |
| AfricanAmerican-vs-Asian |
4.326000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.142120E-02 |
| Normal-vs-Female |
3.775000E-01 |
| Male-vs-Female |
2.378700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.454790E-01 |
| Normal-vs-Extreme_Weight |
5.460600E-03 |
| Normal-vs-Obese |
4.639400E-01 |
| Normal-vs-Extreme_Obese |
4.358200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.713200E-01 |
| Normal_Weight-vs-Obese |
4.465600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.892000E-01 |
| Extreme_Weight-vs-Obese |
5.828200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.195600E-01 |
| Obese-vs-Extreme_Obese |
6.468600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.532200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.596400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.616200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.154100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.078200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.874300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.866300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.793800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.939190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.997600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.329770E-02 |
| Normal-VS-Type2 PRCC |
2.266200E-01 |
| Normal-VS-KIRP CIMP |
1.452410E-01 |
| Normal-VS-Unclassified PRCC |
6.469600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.107200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.774400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.801040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.598000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.405000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.068300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.482300E-02 |
| Normal-vs-N1 |
4.073200E-01 |
| Normal-vs-N2 |
4.614100E-02 |
| N0-vs-N1 |
3.651500E-02 |
| N0-vs-N2 |
4.773600E-01 |
| N1-vs-N2 |
1.278190E-01 |
|
|
